[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
Viral myocarditis—diagnosis, treatment options, and current controversies
A Pollack, AR Kontorovich, V Fuster… - Nature Reviews …, 2015 - nature.com
Myocarditis—a frequent cause of dilated cardiomyopathy and sudden cardiac death—
typically results from cardiotropic viral infection followed by active inflammatory destruction …
typically results from cardiotropic viral infection followed by active inflammatory destruction …
Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection
Summary Coronavirus disease 2019 (COVID-19) is a pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is defined by respiratory …
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is defined by respiratory …
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
Tyrosine kinase inhibitors (TKIs), despite their efficacy as anticancer therapeutics, are
associated with cardiovascular side effects ranging from induced arrhythmias to heart …
associated with cardiovascular side effects ranging from induced arrhythmias to heart …
RNA–protein interaction detection in living cells
RNA–protein interactions play numerous roles in cellular function and disease. Here we
describe RNA–protein interaction detection (RaPID), which uses proximity-dependent …
describe RNA–protein interaction detection (RaPID), which uses proximity-dependent …
Induced pluripotent stem cells 10 years later: for cardiac applications
Y Yoshida, S Yamanaka - Circulation research, 2017 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) are reprogrammed cells that have features similar to
embryonic stem cells, such as the capacity of self-renewal and differentiation into many …
embryonic stem cells, such as the capacity of self-renewal and differentiation into many …
[HTML][HTML] Cardiovascular disease models: a game changing paradigm in drug discovery and screening
H Savoji, MH Mohammadi, N Rafatian, MK Toroghi… - Biomaterials, 2019 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Although investment in
drug discovery and development has been sky-rocketing, the number of approved drugs has …
drug discovery and development has been sky-rocketing, the number of approved drugs has …
[HTML][HTML] Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
C Denning, V Borgdorff, J Crutchley, KSA Firth… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Cardiomyocytes from human pluripotent stem cells (hPSCs-CMs) could revolutionise
biomedicine. Global burden of heart failure will soon reach USD $90 bn, while unexpected …
biomedicine. Global burden of heart failure will soon reach USD $90 bn, while unexpected …
Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine
The prospect of changing the plasticity of terminally differentiated cells toward pluripotency
has completely altered the outlook for biomedical research. Human-induced pluripotent …
has completely altered the outlook for biomedical research. Human-induced pluripotent …
Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association
K Musunuru, F Sheikh, RM Gupta… - Circulation: Genomic …, 2018 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) offer an unprece-dented opportunity to study human
physiology and disease at the cellular level. They also have the potential to be leveraged in …
physiology and disease at the cellular level. They also have the potential to be leveraged in …